Oncorus, Inc.
Pagina dedicata companiei Oncorus, Inc. listata cu simbolul US.ONCR
Descriere companie[edit | ]
Oncorus, Inc. (http://www.mpmcapital.com/) is a clinical-stage biopharmaceutical company. The Company is focused on developing active viral immunotherapies to transform outcomes for cancer patients. Using its two distinct platforms, the Company is developing a pipeline of intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors. Its lead product candidate, ONCR-177, is an intratumorally administered viral immunotherapy based on its oncolytic HSV-1 platform (oHSV Platform), which leverages the Herpes Simplex Virus type 1 (HSV-1). It is also developing a pipeline of product candidates based on its Synthetic Platform. This platform aims to enable repeat intravenous administration of viral immunotherapies in order to treat cancers that are less amenable to intratumoral injection due to safety and feasibility reasons, such as cancers of the lung.
Grafic actiuni companie[edit | ]